nach oben

Lasers in Medical Science

Erschienen in:

29.10.2020 | Original Article

The feasibility and safety of photoselective vaporization for prostate using a 180-W XPS Greenlight laser in day-surgery pattern in China

verfasst von: Ming Xu, Chuanyang Sun, Yachen Zang, Jin Zhu, Boxin Xue, Wei Tao

Erschienen in: Lasers in Medical Science | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the feasibility and safety of photoselective vaporization for prostate (PVP) with a 180-W XPS Greenlight laser as day surgery in the Chinese population. We retrospectively collected 114 cases undergoing the day surgery PVP and 198 cases undergoing conventional inpatient surgery PVP from April 2017 to March 2020. All patients’ data including baseline characteristics, peri-operative data, post-operative outcomes, and complications were recorded and evaluated. The day-surgery procedures were successful in 110 patients. There were no significant differences in baseline characteristics in both groups. The catheterization time and hospitalization time were much shorter and economic cost was much lower in the day-surgery group than in the conventional inpatient surgery group. As for the post-operative complications, the incidence rate of the urinary retention is higher in the day-surgery group than in conventional inpatient surgery group. During the follow-up periods, the International Prostate Symptom Score (IPSS), quality of life (QoL), maximal urinary flow rate (Qmax), and post-void residual urine (PVR) improved significantly in both groups, and no differences were observed between the two groups. Compared to the conventional inpatient surgery, the day-surgery PVP is feasible and safe, which can reduce the hospitalization time and economic cost.

Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50(6):1306–1314CrossRef

Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140CrossRef

Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397CrossRef

Capitan C, Blazquez C, Martin MD et al (2011) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 60(4):734–739CrossRef

Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58(3):349–355CrossRef

Lukacs B, Loefflfler J, Bruyere F et al (2012) Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 61(6):1165–1173CrossRef

Lourenco T, Pickard R, Vale L et al (2008) Benign Prostatic Enlargement t. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomized controlled trials. BMJ 337:a1662CrossRef

Rieken M, Bachmann A, Shariat SF (2016) Long-term results after prostate vaporisation : GreenLight™ laser vaporisation of the prostate and electrovaporisation. Urologe A 55(11):1440–1445CrossRef

Wei JT, Calhoun E, Jacobsen SJ (2008) Urologic Diseases in America project: benign prostatic hyperplasia. J Urol 179(5 Suppl):S75–S80PubMed

10.

Bally CR, Ahuja M, Bartholomew K et al (2019) Guidelines for day-case surgery 2019: guidelines from the Association of Anaesthetists and the British Association of Day Surgery. Anaesthesia 74(6):778–792CrossRef

11.

Jumper C, Snyder P, Yap RL (2012) Rapid ambulatory pathway laser prostatectomy is safe: results within the global period. BJU Int 110(8):1190–1193CrossRef

12.

Aho TF, Gilling PJ, Kennett KM et al (2005) Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: a randomized trial. J Urol 174(1):210–214CrossRef

13.

Larner TR, Agarwal D, Costello AJ (2003) Day-case holmium laser enucleation of the prostate for gland volumes of < 60mL: early experience. BJU Int 91(1):61–64CrossRef

14.

Wang JY, Song XS, Du CJ et al (2014) Guidelines on benign prostatic hyperplasia. Guidelines of CUA 245–267

15.

Muir GGS, Bachmann A, Choi B et al (2008) Techniques and training with GreenLight HPS 120-W laser therapy of the prostate: position paper. Eur Urol Suppl 7:361–392CrossRef

16.

Abdul-Muhsin H, Critchlow W, Navaratnam A et al (2010) Feasibility of Holmium laser enucleation of the prostate as a 1-day surgery. World J Urol 38(4):1017–1025CrossRef

17.

Lwin AA, Zeng J, Evans P et al (2020) Holumium laser enucleation of the prostate is safe and feasible as a same day surgery. Urology 138:119–124CrossRef

18.

Bouchier-Hayes DM, Van Appledorn S, Bugeja P et al (2010) A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 105(7):964–969CrossRef

19.

Goh AC, Gonzalez RR (2010) Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis. J Urol 183(4):1469–1473CrossRef

20.

Berquet G, Corbel L, Della Negra E et al (2015) Prospective evaluation of ambulatory laser vaporization of the prostate for benign prostatic hyperplasia. Lasers Surg Med 47(5):396–402CrossRef

21.

Luo F, Sun HH, Su YH et al (2017) GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine. Lasers Med Sci 32(4):895–901CrossRef

22.

Mou P, Yi L, Wang Y (2016) Photoselective vaporization of the prostate vs plasmakinetic resection of the prostate: a randomized prospective trial with 12-month follow-up in mainland China. Urology 87:161–165CrossRef

23.

Sun J, Shi A, Tong Z et al (2018) Green Light photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml. Lasers Med Sci 33:1693–1698CrossRef

24.

Tao W, Xue BX, Zang YC et al (2013) The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients. Lasers Med Sci 28(3):1151–1157CrossRef

25.

Tao W, Xue BX, Sun CY et al (2019) Comparison of vaporization using 120-W GreenLight laser versus 2-micrometer continuous laser for treating benign prostatic hyperplasia: a 24-month follow-up study of a single center. J Xray Sci Technol 27(4):755–764PubMed

26.

Zang YY, Xue BX, Zhang YY et al (2012) Photoselective vaporization of the prostate with GreenLight HPS 120-W laser for benign prostatic hyperplasia: 36 months’ follow-up. Urol Int 89(2):203–207CrossRef

27.

Meskawi M, Hueber P-A, Valdivieso R et al (2017) Multicenter international experience of 532 nm-laser photovaporization with Greenlight XPS in men with large prostates (prostate volume >100cc). World J Urol 35(10):1603–1609CrossRef

28.

Liatsikos E, Kyriazis I, Kallidonis P et al (2012) Photoselective GreenLight™ laser vaporization versus transurethral resection of the prostate in Greece: a comparative cost analysis. J Endourol 26(2):168–173CrossRef

29.

Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial–the GOLIATH study. Eur Urol 65(5):931–942CrossRef

30.

Tao W, Sun CY, Yang DR et al (2019) Application of 180W XPS Greenlight laser vaporization of the prostate for treatment of benign prostatic hyperplasia. J Xray Sci Technol 27(6):1121–1129PubMed

31.

Xia S, Tong Z, Shi A et al (2020) Exploration of day-surgery photoseletive vaporization of the prostate (PVP) in Chinese population. Lasers in Med Sci 35(7):1503–1507

32.

Larner TR, Agarwal D, Costello AJ (2003) Day-case holmium laser enucleation of the prostate for gland volumes of <60 mL: early experience. BJU Int 91(1):61–64CrossRef

33.

Comat V, Marquette T, Sutter W et al (2017) Day-case holmium laser enucleation of the prostate: prospective evaluation of 90 consecutive cases. J Endourol 31(10):1056–1061CrossRef

34.

Gabbay G, Bernhard JC, Renard O et al (2015) Holmium laser enucleation of the prostate as a day case surgery: prospective evaluation of the first 30 patients. Prog Urol 25(1):34–39CrossRef

35.

Hueber PA, Liberman D, Ben-Zvi T et al (2013) 180W vs 120W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology 82(5):1108–1113CrossRef

36.

Zhou J, Tholomier C, Zanaty M et al (2017) 180W-LBO Greenlight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomes. Can J Urol 24(4):8922–8931PubMed

37.

Plata M, Trujjllo CG, Dominguez C et al (2015) Photoselective vaporization with KTP 180-W green laser for the treatment of lower urinary symptoms secondary to benign prostatic enlargement: effectiveness and safety at midterm follow-up. J Endourol 29(11):1253–1257CrossRef

38.

Ajib K, Mansour M, Zanaty M et al (2018) Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: five-year experience of safety, efficiency, and functional outcomes. Can Urol J Assoc 12(7):318–324CrossRef

Titel: The feasibility and safety of photoselective vaporization for prostate using a 180-W XPS Greenlight laser in day-surgery pattern in China
verfasst von: Ming Xu
Chuanyang Sun
Yachen Zang
Jin Zhu
Boxin Xue
Wei Tao
Publikationsdatum: 29.10.2020
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 7/2021
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-020-03174-0

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The feasibility and safety of photoselective vaporization for prostate using a 180-W XPS Greenlight laser in day-surgery pattern in China

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2021

Effects of photobiomodulation therapy on neuropathic pain in rats: evaluation of nociceptive mediators and infrared thermography

Effects of laser debonding treatment on the optical and mechanical properties of all-ceramic restorations

Nomenclature in thulium laser treatment of benign prostatic hyperplasia: it’s time to pull the rabbit out of the hat

Fractional CO2 laser, platelet rich plasma and narrow band ultraviolet B in the treatment of Vitiligo (A randomized clinical trial)

Bone repair assessment of critical size defects in rats treated with mineralized bovine bone (Bio-Oss®) and photobiomodulation therapy: a histomorphometric and immunohistochemical study

Effect of photobiomodulation therapy on the proliferation phase and wound healing in rats fed with an experimental hypoproteic diet